| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Imagenebio, Inc.
13D
IMA · 45175G207
|
8.4% |
4/21/2026
Event 4/14/2026
|
||||
| Omega Fund VI, L.P. | 8.4% | |||||
| Omega Fund VI GP, L.P. | 8.4% | |||||
| Omega Fund VI GP Manager, Ltd. | 8.4% | |||||
| Claudio Nessi | 8.4% | |||||
| Otello Stampacchia | 8.4% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Lexeo Therapeutics, Inc.
13G/A
LXEO · 52886X107
|
3.6% |
2/14/2025
Event 12/31/2024
|
||||
| Omega Fund VI, L.P. | 3.6% | |||||
| Omega Fund VI GP, L.P. | 3.6% | |||||
| Omega Fund VI GP Manager, Ltd. | 3.6% | |||||
| Claudio Nessi | 3.6% | |||||
| Otello Stampacchia | 3.6% | |||||
| Francesco Draetta | 3.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.